Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the response rate to a gemcitabine-paclitaxel
combination administered on a 3-weekly schedule in Chinese patients with unresectable,
locally recurrent breast cancer or metastatic breast cancer.